Evaxion Reports Preclinical EVX-04 AML Vaccine Data

Evaxion says the data show broad patient coverage, conserved target expression across disease stages and ERV-specific T-cell responses in humanized mice. The company will present the data at the ASH Annual Meeting on December 12–15, 2026.